Surmodics | SRDX - Action





Action Changement Date
Abbott USD 6.49B 220M 2025-12
Align Technology USD 228.16M 15.59M 2025-09
Anika Therapeutics USD 18.79M 2.5M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
Artivion USD 92.43M 1.88M 2025-12
Baxter International USD 2.23B 228M 2025-12
Boston Scientific USD 2.94B 22M 2025-12
EDAP TMS EUR 13.8M 1.73M 2025-09
Edwards Lifesciences USD 1.14B 800K 2025-09
Haemonetics USD 321.18M 15.02M 2025-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
J&J USD 14.19B 45M 2025-12
Merit Medical Systems USD 333.7M 7.15M 2025-12
Mesa Laboratories USD 26.56M 1.18M 2025-12
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Option Care Health USD 471.15M 55.43M 2025-12
Stryker USD 5.31B 60M 2025-12
Surmodics USD 15.17M 230K 2024-09
Trinity Biotech USD 19.16M 210K 2025-09